Vimarsana
Biggest News Aggregation in the World

Patrick Poisson News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Patrick Poisson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Patrick Poisson Today - Breaking & Trending Today

United Therapeutics Corporation to Present at the UBS Biopharma Conference 2023 - Vimarsana News

United Therapeutics Corporation to Present at the UBS Biopharma Conference 2023

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.,--(BUSINESS WIRE)--Oct 31, 2023--

MannKind's Technosphere® Inhalation Platform Utilized in - Vimarsana News

MannKind's Technosphere® Inhalation Platform Utilized in

Tyvaso DPI represents the second FDA-approved product utilizing MannKind’s Technosphere® inhalation technologyFirst approval of a dry powder inhaled...

United Therapeutics Corporation (UTHR) CEO Martine Rothblatt on Q1 2022 Results - Earnings Call Transcript - Vimarsana News

United Therapeutics Corporation (UTHR) CEO Martine Rothblatt on Q1 2022 Results - Earnings Call Transcript

United Therapeutics Corporation (NASDAQ:NASDAQ:UTHR) Q1 2022 Results Conference Call May 04, 2022 09:00 AM ET Company Participants Dewey Steadman - Head, IR Martine Rothblatt - Chairperson,...

05.13.21 -- Biopharma Cold Chain Logistics 101 - Vimarsana News

05.13.21 -- Biopharma Cold Chain Logistics 101

05.13.21 -- Biopharma Cold Chain Logistics 101     Life sciences companies face major challenges to continued operations and profitability including patent expirations, low R&D productivity, increased competition, decreased margins, nonoptimized processes, and mounting compliance pressure. Join us on May 25, 2021 at 11:00 a.m. EDT, to understand the technologies needed to meet today’s requirements, how to spend more time on science and less time correcting data, and how to improve efficiencies in process development, collaboration, and product quality. ...

01.26.21 -- Top 10 Most-Cited MHRA GMP Inspection Deficiencies - Vimarsana News

01.26.21 -- Top 10 Most-Cited MHRA GMP Inspection Deficiencies

01.26.21 -- Top 10 Most-Cited MHRA GMP Inspection Deficiencies   Continuing our Cell & Gene series, Business of Biotech features Dr. Bobby Gaspar, Orchard Therapeutics CEO, speaking on the challenges his company faces in the production of hematopoietic stem cells to treat neurometabolic disorders, primary immune deficiencies, and blood disorders. Listen now and subscribe so you never miss an episode. Featured Editorial By Barbara Unger, Unger Consulting Inc. In Part 1 of this two-part article, we evaluated the U.K. Medicines and Healthcare products Regulato...